HOLX Hologic Inc

Price (delayed)

$66.75

Market cap

$14.87B

P/E Ratio

27.93

Dividend/share

N/A

EPS

$2.39

Enterprise value

$15.98B

Hologic, Inc. is a medical technology company primarily focused on women’s health; it sells medical devices for diagnostics, surgery, and medical imaging. In late November 2013, activist investor Carl Icahn ...

Highlights
Hologic's net income has decreased by 25% QoQ but it has increased by 19% YoY
The EPS has declined by 25% since the previous quarter but it is up by 22% year-on-year
The stock's price to earnings (P/E) is 31% more than its 5-year quarterly average of 21.1 and 13% more than its last 4 quarters average of 24.4
Hologic's quick ratio has decreased by 23% YoY and by 12% QoQ

Key stats

What are the main financial stats of HOLX
Market
Shares outstanding
222.85M
Market cap
$14.87B
Enterprise value
$15.98B
Valuations
Price to earnings (P/E)
27.93
Price to book (P/B)
3.24
Price to sales (P/S)
3.74
EV/EBIT
19.85
EV/EBITDA
14.5
EV/Sales
3.97
Earnings
Revenue
$4.03B
Gross profit
$2.08B
Operating income
$696.8M
Net income
$556.7M
EBIT
$804.7M
EBITDA
$1.1B
Free cash flow
$985.5M
Per share
EPS
$2.39
EPS diluted
$2.36
Free cash flow per share
$4.36
Book value per share
$20.58
Revenue per share
$17.83
TBVPS
$18.81
Balance sheet
Total assets
$8.55B
Total liabilities
$3.93B
Debt
$2.53B
Equity
$4.62B
Working capital
$2.22B
Liquidity
Debt to equity
0.55
Current ratio
3.24
Quick ratio
2.29
Net debt/EBITDA
1
Margins
EBITDA margin
27.4%
Gross margin
51.6%
Net margin
13.8%
Operating margin
17.3%
Efficiency
Return on assets
6.3%
Return on equity
11.4%
Return on invested capital
19.1%
Return on capital employed
10.7%
Return on sales
20%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

HOLX stock price

How has the Hologic stock price performed over time
Intraday
0.98%
1 week
4.31%
1 month
3.86%
1 year
-14.29%
YTD
-7.41%
QTD
2.44%

Financial performance

How have Hologic's revenue and profit performed over time
Revenue
$4.03B
Gross profit
$2.08B
Operating income
$696.8M
Net income
$556.7M
Gross margin
51.6%
Net margin
13.8%

HOLX financials

Hologic's operating income has increased by 29% YoY but it has decreased by 24% QoQ
The operating margin has grown by 26% YoY but it has contracted by 23% from the previous quarter
The company's net margin fell by 25% QoQ but it rose by 17% YoY
Hologic's net income has decreased by 25% QoQ but it has increased by 19% YoY

Price vs fundamentals

How does HOLX's price correlate with its fundamentals

HOLX Price vs fundamentals

HOLX Earnings waterfall

HOLX Price vs fair value

Growth

What is Hologic's growth rate over time

HOLX growth chart

Valuation

What is Hologic stock price valuation
P/E
27.93
P/B
3.24
P/S
3.74
EV/EBIT
19.85
EV/EBITDA
14.5
EV/Sales
3.97

Valuation vs average

Price to earnings (P/E)

The stock's price to earnings (P/E) is 31% more than its 5-year quarterly average of 21.1 and 13% more than its last 4 quarters average of 24.4
The EPS has declined by 25% since the previous quarter but it is up by 22% year-on-year

Price to book (P/B)

HOLX's price to book (P/B) is 20% lower than its 5-year quarterly average of 4.0 and 6% lower than its last 4 quarters average of 3.4
HOLX's equity is down by 4.7% year-on-year and by 3.2% since the previous quarter

Price to sales (P/S)

HOLX's price to sales (P/S) is 12% lower than its last 4 quarters average of 4.2 and 7% lower than its 5-year quarterly average of 4.0

Efficiency

How efficient is Hologic business performance
The ROE has contracted by 25% from the previous quarter but it has grown by 20% YoY
Hologic's return on assets has decreased by 25% QoQ but it has increased by 21% YoY
HOLX's return on invested capital is down by 24% since the previous quarter but it is up by 15% year-on-year
The return on sales has declined by 23% since the previous quarter but it is up by 18% year-on-year

Dividends

What is HOLX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for HOLX.

Financial health

How did Hologic financials performed over time

Assets vs liabilities

The total assets is 118% higher than the total liabilities
Hologic's quick ratio has decreased by 23% YoY and by 12% QoQ
Hologic's current ratio has decreased by 18% YoY and by 7% from the previous quarter

Debt vs equity

The company's debt is 45% lower than its equity
HOLX's equity is down by 4.7% year-on-year and by 3.2% since the previous quarter
Hologic's debt to equity has increased by 3.8% from the previous quarter and by 3.8% YoY

Balance sheet

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.